Video

CAR T-Cell Therapy in R/R LBCL: TRANSFORM, ZUMA-7, and PILOT Studies

Author(s):

Manali Kamdar, MD,Matthew A. Lunning, DO, FACP

In the context of CAR T-cell therapy, Manali Kamdar, MD, reviews TRANSFORM, ZUMA-7, and PILOT trials in the treatment of patients with relapsed-refractory (R/R) large B-cell lymphoma (LBCL).

Newsletter

Stay up to date on the most recent and practice-changing oncology data

Subscribe Now!
Related Videos
Alfred L. Garfall, MD
Grzegorz S. Nowakowsi, MD, a consultant in the Division of Hematology in the Department of Internal Medicine and the Enterprise Deputy Director of Clinical Research at the Mayo Clinic Comprehensive Cancer Center
Daniel J. George, MD, and Matthew Smith, MD, PhD, discuss ongoing research to watch in prostate cancer.
Daniel J. George, MD, and Matthew Smith, MD, PhD, discuss other key prostate cancer data presented at ASCO GU 2025.
Daniel J. George, MD, and Matthew Smith, MD, PhD, discuss data from a real-world analysis for AR inhibitors in nmCRPC.
Daniel J. George, MD, and Matthew Smith, MD, PhD, discuss a subgroup analysis from the ARANOTE trial in prostate cancer.
Daniel J. George, MD, and Matthew Smith, MD, PhD, discuss an age-based subgroup analysis from the ARASENS trial in prostate cancer.
Julie M. Vose, MD, MBA
Daniel J. George, MD, and Matthew Smith, MD, PhD, discuss the evolution of treatment for metastatic hormone-sensitive prostate cancer.
Marco Davila, MD, PhD, the senior vice president and associate director for Translational Research in the Department of Medicine, as well as the Rustum Family Endowed Chair in Translational Research at Roswell Park Comprehensive Cancer Center
Related Content
Grzegorz S. Nowakowski, MD, of Mayo Clinic
March 19th 2025

Brentuximab Vedotin Combo Adds Another Targeted Option Beyond CD19/CD20 in R/R LBCL

Matthew Lunning, DO, FACP
December 21st 2023

Lunning and Mehta-Shah Unpack Treatment Needs and Future Directions in PTCL

Follicular Lymphoma | Image Credit: © LASZLO – stock.adobe.com
March 14th 2025

Liso-Cel Receives European Approval in Relapsed/Refractory Follicular Lymphoma

Matthew Lunning, DO, FACP
October 30th 2023

Lunning and Nastoupil Highlight Treatment Considerations and Ongoing Research in Follicular Lymphoma

Renier Brentjens, MD, PhD, chair of the Department of Medicine, the Katherine Anne Gioia Endowed Chair in Cancer Medicine, deputy director, and a professor of oncology at Roswell Park Comprehensive Cancer Center
March 12th 2025

Investigators Are Making Headway Bringing CAR T-Cell Therapy to Solid Tumors

Multiple Myeloma | Image Credit: © Свет Лана – stock.adobe.com
March 12th 2025

Anti-CD38-CAR-γδ T Cells Show Preclinical Cytotoxicity in Myeloma